Showing results (41-50 of 52) with videos related to
Sort By:
Pageof 6
Anticancer Research|January 1, 2015
Comparative analysis of tumor angiogenesis and clinical features of 55 cases of pleomorphic carcinoma and adenocarcinoma of the lungYukari Tsubata, Akihisa Sutani, Tamio Okimoto, et al.Anticancer Research|July 31, 2012
Tumor angiogenesis in 75 cases of pleomorphic carcinoma of the lungYukari Tsubata, Akihisa Sutani, Tamio Okimoto, et al.BMC Cancer|October 19, 2021
Phase II study of multidisciplinary therapy combined with pembrolizumab for patients with synchronous oligometastatic non-small cell lung cancer TRAP OLIGO study (WJOG11118L)Taichi Miyawaki, Hirotsugu Kenmotsu, Hideyuki Harada, et al.Anticancer Research|June 13, 2014
Immunohistochemical comparison of biomarker expression in biopsy and surgical specimens of non-small cell lung cancerTamio Okimoto, Yukari Tsubata, Akihisa Sutani, et al.The Journal of Medical Investigation : JMI|November 11, 2021
Ability of the Glasgow Prognostic Score to predict the tolerability and efficacy of platinum-combination chemotherapy among elderly patients with advanced non-small cell lung cancerKazuhisa Nakashima, Kojiro Hata, Takamasa Hotta, et al.Geriatrics & Gerontology International|November 21, 2019
Prospective clinical trial evaluating vulnerability and chemotherapy risk using geriatric assessment tools in older patients with lung cancerYukari Tsubata, Yohei Shiratsuki, Takae Okuno, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|May 7, 2013
Efficacy and safety of piperacillin/tazobactam versus biapenem in late elderly patients with nursing- and healthcare-associated pneumoniaFumi Karino, Kiyotaka Miura, Hiroshi Fuchita, et al.European Journal of Cancer (Oxford, England : 1990)|July 10, 2025
The clinical potential of HMGB1 for the risk assessment of severe checkpoint inhibitor pneumonitis: A prospective multicenter study (CS-Lung004)Kakuhiro Yamaguchi, Shun Takao, Nobuhiro Kanaji, et al.Nature Immunology|October 20, 2022
SUSD2 suppresses CD8+ T cell antitumor immunity by targeting IL-2 receptor signalingBao Zhao, Weipeng Gong, Anjun Ma, et al.Journal of Extracellular Vesicles|September 12, 2022
An immunogold single extracellular vesicular RNA and protein (Au SERP) biochip to predict responses to immunotherapy in non-small cell lung cancer patientsLuong T H Nguyen, Jingjing Zhang, Xilal Y Rima, et al.Pageof 6